Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293114.RA6fZPYU_mR5kQpFnfp-1rlKVXpLUlhHADTtuUbmi36Zk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293114.RA6fZPYU_mR5kQpFnfp-1rlKVXpLUlhHADTtuUbmi36Zk130_assertion type Assertion NP1293114.RA6fZPYU_mR5kQpFnfp-1rlKVXpLUlhHADTtuUbmi36Zk130_head.
- NP1293114.RA6fZPYU_mR5kQpFnfp-1rlKVXpLUlhHADTtuUbmi36Zk130_assertion description "[Reactivation of the MAPK pathway via either a gain in the number of copies of the gene encoding wild-type K-RAS (KRAS(WT)) or decreased expression of the MAPK phosphatase DUSP6 promoted resistance to ALK inhibitors in vitro, and each was associated with resistance to ALK inhibitors in individuals with EML4-ALK-positive lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293114.RA6fZPYU_mR5kQpFnfp-1rlKVXpLUlhHADTtuUbmi36Zk130_provenance.
- NP1293114.RA6fZPYU_mR5kQpFnfp-1rlKVXpLUlhHADTtuUbmi36Zk130_assertion evidence source_evidence_literature NP1293114.RA6fZPYU_mR5kQpFnfp-1rlKVXpLUlhHADTtuUbmi36Zk130_provenance.
- NP1293114.RA6fZPYU_mR5kQpFnfp-1rlKVXpLUlhHADTtuUbmi36Zk130_assertion SIO_000772 26301689 NP1293114.RA6fZPYU_mR5kQpFnfp-1rlKVXpLUlhHADTtuUbmi36Zk130_provenance.
- NP1293114.RA6fZPYU_mR5kQpFnfp-1rlKVXpLUlhHADTtuUbmi36Zk130_assertion wasDerivedFrom befree-2016 NP1293114.RA6fZPYU_mR5kQpFnfp-1rlKVXpLUlhHADTtuUbmi36Zk130_provenance.
- NP1293114.RA6fZPYU_mR5kQpFnfp-1rlKVXpLUlhHADTtuUbmi36Zk130_assertion wasGeneratedBy ECO_0000203 NP1293114.RA6fZPYU_mR5kQpFnfp-1rlKVXpLUlhHADTtuUbmi36Zk130_provenance.